- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Andaris agent enters renal study
Ultrasound contrast developer Andaris is exploring radiological applications for its Quantison agent. The Nottingham, U.K.-based company has begun a phase II clinical trial to examine the efficiency of the intravenous agent during renal imaging. To be
Ultrasound contrast developer Andaris is exploring radiological applications for its Quantison agent. The Nottingham, U.K.-based company has begun a phase II clinical trial to examine the efficiency of the intravenous agent during renal imaging. To be conducted at the University Hospital Dijkzigt in Rotterdam, the Netherlands, the trial will employ Quantison during renal imaging in patients with hypertension resulting from renal artery stenosis that was proven angiographically.
Quantison, which consists of a 3-micron air-filled albumin microcapsule, was initially designed for myocardial perfusion and cardiac chamber analysis; previous clinical studies have showed good results in both left ventricular opacification and myocardial perfusion, according to the company. In February, company executives said that Quantison might also be suitable for peripheral vascular and general radiology applications (SCAN 2/5/97).
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
